Milan 2012 Programme Registration Exhibition Hotels Exhibitor Listing Satellite Meetings Visa Information
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Artiflex toric phakic intraocular lens for myopic astigmatism

Poster Details

First Author: G.Mu SPAIN

Co Author(s):    A. Cardoner   C. Albarr   T. Ferrer Blasco   L. Belda Salmer     

Abstract Details


To evaluate visual outcomes and complications of the foldable Artiflex toric iris-fixated intraocular lens (Ophtec BV, The Netherlands) for the correction of myopic astigmatism in phakic eyes.


Private practice surgery centers, Valencia and Terrassa, Spain


Forty-two eyes of 25 patients underwent implantation of the foldable iris-fixated toric phakic intraocular lens (pIOL). At 12 months, the refraction, uncorrected (UDVA) and corrected (CDVA) distance visual acuities, complications, pIOL misalignment, and endothelial cell count (ECC) were evaluated


Spherical equivalent was reduced from -8.85 ± 2.71 diopters (D) to ?0.37 ± 0.46 D. Mean cylinder power decreased from -2.90 D (range -1.50 to -5.00 D) to -0.39 D (range 0.00 to -1.50 D). All eyes achieved UDVA of 0.5 (20/40) or better, and CDVA of 0.8 (20/25) or better. A gain of 1 line or more of CDVA was found in 69.1% of eye; no eye lost 1 or more lines of CDVA. Refraction was highly stable. The mean ECC decrease was 9.3%. Iris pigment precipitates were observed in 16.7% of eyes


After 1 years of follow-up, the implantation of the foldable iris-fixated Artiflex toric pIOL proved to be effective, predictable, safe and stable for the correction of myopic astigmatism FINANCIAL DISCLOSURE?: No

Back to previous

loading Please wait while information is loading.